Dipiperidines as a new class of anti-TB drug

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43AI060250-01
Agency Tracking Number: AI060250
Amount: $299,475.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
SEQUELLA, INC., 9610 MEDICAL CENTER DR, STE 200, ROCKVILLE, MD, 20850
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 MARINA Protopopova
 (301) 217-3832
 MARINAPROTOPOPOVA@SEQUELLA.COM
Business Contact
Phone: (301) 762-7776
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The overall aim of this application is to characterize a new class of drugs to treat tuberculosis (TB) that are structurally unrelated to any existing anti-TB drugs. Three years ago, Sequella received a Challenge gran

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government